Shares of Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $15.51 and last traded at $15.65, with a volume of 460319 shares trading hands. The stock had previously closed at $15.55.
Analysts Set New Price Targets
Separately, StockNews.com lowered Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd.
Get Our Latest Stock Report on Avanos Medical
Avanos Medical Trading Up 0.5 %
The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The firm has a market capitalization of $717.85 million, a price-to-earnings ratio of 45.94 and a beta of 0.99. The firm's 50-day simple moving average is $18.19 and its 200 day simple moving average is $21.04.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Natixis Advisors LLC increased its holdings in shares of Avanos Medical by 19.5% during the second quarter. Natixis Advisors LLC now owns 18,878 shares of the company's stock worth $376,000 after buying an additional 3,077 shares in the last quarter. Quest Partners LLC acquired a new position in shares of Avanos Medical in the second quarter valued at approximately $444,000. American Century Companies Inc. boosted its position in Avanos Medical by 12.1% during the 2nd quarter. American Century Companies Inc. now owns 82,930 shares of the company's stock worth $1,652,000 after buying an additional 8,929 shares during the period. Cornercap Investment Counsel Inc. acquired a new stake in Avanos Medical during the 2nd quarter worth approximately $1,077,000. Finally, Federated Hermes Inc. grew its stake in shares of Avanos Medical by 4.2% in the second quarter. Federated Hermes Inc. now owns 97,097 shares of the company's stock worth $1,934,000 after purchasing an additional 3,938 shares during the last quarter. Institutional investors own 95.17% of the company's stock.
Avanos Medical Company Profile
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
